Levetiracetam Sandoz (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces hyper‑excitability, thereby decreasing the likelihood of seizure propagation without directly influencing ion channels.

The appropriate dose of levetiracetam is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. The prescriber determines the starting dose and any subsequent titration to achieve optimal seizure control.

Safety data for levetiracetam during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a relatively simple pharmacokinetic profile, fewer drug‑enzyme interactions, and does not require routine blood‑level monitoring. However, individual response varies, and some patients may experience mood‑related side effects more frequently.

Levetiracetam Sandoz should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme heat.

The medication is taken orally, usually as a whole tablet swallowed with water. It can be taken with or without food, and the dosing schedule (once or twice daily) is determined by the prescriber based on therapeutic response.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, emergence of suicidal thoughts or depressive symptoms, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, swelling, mood changes, or unexplained bruising.

Levetiracetam should be avoided in individuals with known hypersensitivity to the drug or any of its components. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those with a history of psychiatric disorders.